173 related articles for article (PubMed ID: 12656816)
1. Adjuvant cytokeratin staining in Mohs micrographic surgery for basal cell carcinoma.
Smeets NW; Stavast-Kooy AJ; Krekels GA; Daemen MJ; Neumann HA
Dermatol Surg; 2003 Apr; 29(4):375-7. PubMed ID: 12656816
[TBL] [Abstract][Full Text] [Related]
2. Innovative 19-minute rapid cytokeratin immunostaining of nonmelanoma skin cancer in Mohs micrographic surgery.
Cherpelis BS; Turner L; Ladd S; Glass LF; Fenske NA
Dermatol Surg; 2009 Jul; 35(7):1050-6. PubMed ID: 19469800
[TBL] [Abstract][Full Text] [Related]
3. A pilot study comparing toluidine blue and hematoxylin and eosin staining of basal cell and squamous cell carcinoma during Mohs surgery.
Humphreys TR; Nemeth A; McCrevey S; Baer SC; Goldberg LH
Dermatol Surg; 1996 Aug; 22(8):693-7. PubMed ID: 8780761
[TBL] [Abstract][Full Text] [Related]
4. Dense inflammation does not mask residual primary basal cell carcinoma during Mohs micrographic surgery.
Katz KH; Helm KF; Billingsley EM; Maloney ME
J Am Acad Dermatol; 2001 Aug; 45(2):231-8. PubMed ID: 11464184
[TBL] [Abstract][Full Text] [Related]
5. A comparison of touch imprint cytology and Mohs frozen-section histology in the evaluation of Mohs micrographic surgical margins.
Florell SR; Layfield LJ; Gerwels JW
J Am Acad Dermatol; 2001 Apr; 44(4):660-4. PubMed ID: 11260543
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical techniques in Mohs micrographic surgery: their potential use in the detection of neoplastic cells masked by inflammation.
Jimenez FJ; Grichnik JM; Buchanan MD; Clark RE
J Am Acad Dermatol; 1995 Jan; 32(1):89-94. PubMed ID: 7529778
[TBL] [Abstract][Full Text] [Related]
7. Basal cell carcinoma: rapid techniques using cytokeratin markers to assist treatment by micrographic (Mohs') surgery.
Ramnarain ND; Walker NP; Markey AC
Br J Biomed Sci; 1995 Sep; 52(3):184-7. PubMed ID: 8527995
[TBL] [Abstract][Full Text] [Related]
8. Peritumoral fibrosis in basal cell and squamous cell carcinoma mimicking perineural invasion: potential pitfall in Mohs micrographic surgery.
Hassanein AM; Proper SA; Depcik-Smith ND; Flowers FP
Dermatol Surg; 2005 Sep; 31(9 Pt 1):1101-6. PubMed ID: 16164857
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of curettage in delineating margins of basal cell carcinoma before Mohs micrographic surgery.
Ratner D; Bagiella E
Dermatol Surg; 2003 Sep; 29(9):899-903. PubMed ID: 12930329
[TBL] [Abstract][Full Text] [Related]
10. Hematoxylin and eosin tissue stain in Mohs micrographic surgery: a review.
Larson K; Ho HH; Anumolu PL; Chen TM
Dermatol Surg; 2011 Aug; 37(8):1089-99. PubMed ID: 21635628
[TBL] [Abstract][Full Text] [Related]
11. Comparison of ex vivo optical coherence tomography with conventional frozen-section histology for visualizing basal cell carcinoma during Mohs micrographic surgery.
Cunha D; Richardson T; Sheth N; Orchard G; Coleman A; Mallipeddi R
Br J Dermatol; 2011 Sep; 165(3):576-80. PubMed ID: 21797838
[TBL] [Abstract][Full Text] [Related]
12. In vivo real-time confocal reflectance microscopy: a noninvasive guide for Mohs micrographic surgery facilitated by aluminum chloride, an excellent contrast enhancer.
Tannous Z; Torres A; González S
Dermatol Surg; 2003 Aug; 29(8):839-46. PubMed ID: 12859385
[TBL] [Abstract][Full Text] [Related]
13. Formalin-fixed tissue Mohs surgery (slow Mohs) for basal cell carcinoma: 5-year follow-up data.
Lawrence CM; Haniffa M; Dahl MG
Br J Dermatol; 2009 Mar; 160(3):573-80. PubMed ID: 19210500
[TBL] [Abstract][Full Text] [Related]
14. Interpretation of Mohs micrographic frozen sections: a peer review comparison study.
Grabski WJ; Salasche SJ; McCollough ML; Berkland ME; Gutierrez JA; Finstuen K
J Am Acad Dermatol; 1989 Apr; 20(4):670-4. PubMed ID: 2715412
[TBL] [Abstract][Full Text] [Related]
15. Novel 16-minute technique for evaluating melanoma resection margins during Mohs surgery.
Chang KH; Finn DT; Lee D; Bhawan J; Dallal GE; Rogers GS
J Am Acad Dermatol; 2011 Jan; 64(1):107-12. PubMed ID: 21167405
[TBL] [Abstract][Full Text] [Related]
16. Rapid toluidine blue stain for Mohs' micrographic surgery.
Todd MM; Lee JW; Marks VJ
Dermatol Surg; 2005 Feb; 31(2):244-5. PubMed ID: 15762224
[TBL] [Abstract][Full Text] [Related]
17. The use of antidesmoglein stains in Mohs micrographic surgery. A potential aid for the differentiation of basal cell carcinoma from horizontal sections of the hair follicle and folliculocentric basaloid proliferation.
Krunic AL; Garrod DR; Viehman GE; Madani S; Buchanan MD; Clark RE
Dermatol Surg; 1997 Jun; 23(6):463-8. PubMed ID: 9217798
[TBL] [Abstract][Full Text] [Related]
18. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.
Smeets NW; Kuijpers DI; Nelemans P; Ostertag JU; Verhaegh ME; Krekels GA; Neumann HA
Br J Dermatol; 2004 Jul; 151(1):141-7. PubMed ID: 15270883
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical staining of lentigo maligna during Mohs micrographic surgery using MART-1.
Kelley LC; Starkus L
J Am Acad Dermatol; 2002 Jan; 46(1):78-84. PubMed ID: 11756950
[TBL] [Abstract][Full Text] [Related]
20. Rapid HMB-45 staining in Mohs micrographic surgery for melanoma in situ and invasive melanoma.
Menaker GM; Chiang JK; Tabila B; Moy RL
J Am Acad Dermatol; 2001 May; 44(5):833-6. PubMed ID: 11312433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
